Cancer Genomics: Molecular Profile Interpretation 101

Total Health

L. Welch

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

GI and Hepatic Complications of Cancer Immunotherapy

Michigan Medicine

R. Fontana

Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated …

Total Health

M. Armstrong

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Insights on Pediatric Cancer for Childhood Cancer Awareness

Oncology Data Advisor

T. Knight

T-Cell Exhaustion in Chronic Viral Infection and Cancer: Implication…

Yale Cancer Center

R. Ahmed

Novel Approaches to Tumor Microenvironment Modulation for Enhanced C…

Moffitt Cancer Center

R. Romee

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

Breaking Boundaries: The Science Behind Immune Tolerance in Cancer

Yale Cancer Center

M. Mamula, E. Winer

Developing Novel Therapeutics for Brain Tumors in the Age of Genomic…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

E. Galanis

2024 Update in Oncologic Emergencies

UNC Lineberger Comprehensive Cancer Center

J. Stein

Potential Mechanisms of Resistance to ADCs

MI&T Congressi

J. Bar

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

C. Jackson

Characterizing the Immune Microenvironments of Brain Metastases

MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

P. Siegel

Tumor Immune Microenvironment and Immunotherapy Resistance

MI&T Congressi

D. Sangiolo

The Immunology of Immune Cell Cancers

Tanaya Shree

Perioperative Considerations for Tumor Tissue Procurement to Obtain …

Moffitt Cancer Center

J. Mullinax